logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On January 15, IFBH (06603) spent 3.5907 million Hong Kong dollars to repurchase 21.14 thousand shares.

date
22:06 15/01/2026
avatar
GMT Eight
IFBH (06603) issued an announcement to repurchase 211,400 shares at a cost of 3.5907 million Hong Kong dollars on January 15, 2026.
IFBH (06603) announced that it will buy back 211,400 shares at a cost of HK$3.5907 million on January 15, 2026.
Related Articles
US Stock Market Move | Morgan Stanley(MS.US) rose more than 4% in Q4, with investment banking revenue soaring 47%.
US Stock Market Move | Weight loss drug sector stocks fall, Eli Lilly (LLY.US) plummets over 5%
US Stock Market Move | Burning Rock Biotech Ltd. Sponsored ADR Class A (BNR.US) rose more than 10% as it developed the OncoCompass technology to empower precise diagnosis and treatment of tumors.
US Stock Market Move | Morgan Stanley(MS.US) rose more than 4% in Q4, with investment banking revenue soaring 47%.
US Stock Market Move | Weight loss drug sector stocks fall, Eli Lilly (LLY.US) plummets over 5%
US Stock Market Move | Burning Rock Biotech Ltd. Sponsored ADR Class A (BNR.US) rose more than 10% as it developed the OncoCompass technology to empower precise diagnosis and treatment of tumors.
RECOMMEND
Wall Street Alert: Trump’s Confrontation With The Fed Could Elevate Rates And Threaten Market Stability
Wall Street Alert: Trump’s Confrontation With The Fed Could Elevate Rates And Threaten Market Stability
icon
14/01/2026
Dual Large‑Model Leaders Propel Hong Kong Stocks Higher As AI Applications Diversify
Dual Large‑Model Leaders Propel Hong Kong Stocks Higher As AI Applications Diversify
icon
14/01/2026
A‑Shares Open The Year With Consecutive Gains While Hong Kong Stocks Lag
A‑Shares Open The Year With Consecutive Gains While Hong Kong Stocks Lag
icon
14/01/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.